List view / Grid view




A strong EU IP framework guarantees future innovation for patients

19 May 2017 | By European Federation of Pharmaceutical Industries and Associations (EFPIA)

Intellectual Property (IP) could be considered the foundation for pharmaceutical innovation. In healthcare, innovation means improved health outcomes: avoiding illness; slowing disease progression; improving patients’ lives; and reducing overall costs for healthcare systems. With over 80 medicines approved every year – including some 30 new, approved substances – and over…


EFPIA releases statement on Brexit

30 June 2016 | By Victoria White, Digital Content Producer

In the statement, EFPIA underscores the importance of ensuring that the patient is at the centre of all subsequent decisions...


Reactions to the EU Referendum

24 June 2016 | By Victoria White, Digital Content Producer

The BioIndustry Association and EFPIA have reacted to the news that Britain has voted to leave the European Union (EU)...